RU2322444C2 - Соединения оксазолидинона, обладающие антибактериальной активностью, способ получения (варианты) и фармацевтическая композиция на их основе - Google Patents

Соединения оксазолидинона, обладающие антибактериальной активностью, способ получения (варианты) и фармацевтическая композиция на их основе Download PDF

Info

Publication number
RU2322444C2
RU2322444C2 RU2003123104/04A RU2003123104A RU2322444C2 RU 2322444 C2 RU2322444 C2 RU 2322444C2 RU 2003123104/04 A RU2003123104/04 A RU 2003123104/04A RU 2003123104 A RU2003123104 A RU 2003123104A RU 2322444 C2 RU2322444 C2 RU 2322444C2
Authority
RU
Russia
Prior art keywords
oxazolan
oxo
phenyl
salts
ylmethyl
Prior art date
Application number
RU2003123104/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2003123104A (ru
Inventor
Сельвакумар НАТЕСАН (IN)
Сельвакумар НАТЕСАН
Джагаттаран ДАС (IN)
Джагаттаран Дас
Джавед ИКБАЛ (IN)
Джавед Икбал
Ситарам Кумар МАГАДИ (IN)
Ситарам Кумар Магади
Нага Венката Сриниваса Рао МАМИДИ (IN)
Нага Венката Сриниваса Рао МАМИДИ
Раджагопалан РАМАНУДЖАМ (IN)
Раджагопалан Рамануджам
Баскаран СУНДАРАБАБУ (IN)
Баскаран СУНДАРАБАБУ
Брадж Бхушан ЛОХРЭЙ (IN)
Брадж Бхушан ЛОХРЭЙ
Original Assignee
Др. Редди`З Лабораториз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Др. Редди`З Лабораториз Лтд. filed Critical Др. Редди`З Лабораториз Лтд.
Publication of RU2003123104A publication Critical patent/RU2003123104A/ru
Application granted granted Critical
Publication of RU2322444C2 publication Critical patent/RU2322444C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2003123104/04A 2000-12-26 2001-12-26 Соединения оксазолидинона, обладающие антибактериальной активностью, способ получения (варианты) и фармацевтическая композиция на их основе RU2322444C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1124MA2000 2000-12-26
IN1124/MAS/2000 2000-12-26
IN15MA2001 2001-01-15
IN15/MAS/2001 2001-01-15

Publications (2)

Publication Number Publication Date
RU2003123104A RU2003123104A (ru) 2005-03-10
RU2322444C2 true RU2322444C2 (ru) 2008-04-20

Family

ID=26324889

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003123104/04A RU2322444C2 (ru) 2000-12-26 2001-12-26 Соединения оксазолидинона, обладающие антибактериальной активностью, способ получения (варианты) и фармацевтическая композиция на их основе

Country Status (21)

Country Link
US (2) US7030148B2 (enExample)
EP (1) EP1345913A2 (enExample)
JP (1) JP2004525876A (enExample)
KR (1) KR20030063472A (enExample)
CN (1) CN1656083A (enExample)
BG (1) BG108022A (enExample)
BR (1) BR0116571A (enExample)
CA (1) CA2433138A1 (enExample)
CZ (1) CZ20031799A3 (enExample)
EE (1) EE200300254A (enExample)
HR (1) HRP20030522A2 (enExample)
HU (1) HUP0302580A2 (enExample)
IL (1) IL156662A0 (enExample)
MX (1) MXPA03005822A (enExample)
NO (1) NO20032926L (enExample)
NZ (1) NZ526716A (enExample)
PL (1) PL363616A1 (enExample)
RU (1) RU2322444C2 (enExample)
SK (1) SK8202003A3 (enExample)
WO (1) WO2002051819A2 (enExample)
YU (1) YU52403A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163043B2 (en) 2003-12-18 2015-10-20 Dong-A St Co., Ltd. Oxazolidinone derivatives
US9624250B2 (en) 2009-02-03 2017-04-18 Merck Sharp & Dohme Corp. Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
AU2002329393B2 (en) 2001-09-11 2008-06-12 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
US20060293315A1 (en) * 2001-12-21 2006-12-28 Dr. Reddy's Laboratories Ltd. Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation
US6914058B2 (en) * 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
US7141561B2 (en) 2002-07-25 2006-11-28 Sanofi-Aventis Deutschland Gmbh Substituted diaryl heterocycles, process for their preparation and their use as medicaments
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2003215861A1 (en) * 2003-04-07 2004-11-01 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
AU2004256085B2 (en) * 2003-07-02 2007-12-06 Kyorin, Pharmaceutical Co., Ltd. Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof
MXPA06000228A (es) 2003-07-02 2006-06-27 Merck & Co Inc Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos.
WO2005035528A2 (en) * 2003-10-14 2005-04-21 Dr. Reddy's Laboratories Ltd. Triazole derivatives as antibacterial agents
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
CN101720325B (zh) * 2007-08-06 2013-04-24 上海盟科药业有限公司 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
MX2011001872A (es) * 2008-08-18 2011-05-23 Univ Yale Moduladores de mif.
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
CN101798302B (zh) * 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
WO2014045292A1 (en) * 2012-09-20 2014-03-27 Symed Labs Limited Improved process for the preparation of linezolid intermediate
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2015127316A1 (en) 2014-02-21 2015-08-27 Micurx Pharmaceuticals, Inc. Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
GB2550437B (en) * 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
US12109203B2 (en) 2018-07-25 2024-10-08 Zydus Lifesciences Limited Substituted oxazolidinones for the treatment of mammalian infections
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections
CN110301433A (zh) * 2019-07-25 2019-10-08 河南精怡达生物科技有限公司 一种含有微量元素组合的猪精液体外常温保存剂

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007271A1 (en) * 1993-09-09 1995-03-16 The Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
WO1996013502A1 (en) * 1994-10-26 1996-05-09 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
WO1997027188A1 (en) * 1996-01-27 1997-07-31 Zeneca Limited Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
RU2105003C1 (ru) * 1992-05-08 1998-02-20 Дзе Апджон Компани Производное оксазолидинона или его фармацевтически приемлемая соль, способ лечения микробных инфекций у теплокровных животных

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987505A (en) * 1958-03-04 1961-06-06 Gen Aniline & Film Corp Compositions of polymeric nu-vinyl-2-oxazolidone and halogens
US3651079A (en) 1968-11-25 1972-03-21 Colgate Palmolive Co 1-aryl-5-hydroxyalkyl-hydantoins
GB1408010A (en) * 1972-11-20 1975-10-01 Geistlich Soehne Ag Sulphamoylphenyl-imidazolidinones
US4174958A (en) 1978-01-09 1979-11-20 Shell Oil Company Anilide derivative herbicides
FR2571364B1 (fr) * 1984-10-09 1987-07-17 Oreal Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
US6087496A (en) * 1998-05-22 2000-07-11 G. D. Searle & Co. Substituted pyrazoles suitable as p38 kinase inhibitors
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
CN1367780A (zh) 1999-07-28 2002-09-04 法玛西雅厄普约翰美国公司 噁唑烷酮类化合物、其制备方法及其应用
GB0118407D0 (en) 2001-07-27 2001-09-19 Cipla Ltd Oxazolidinone derivatives as antibacterial agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2105003C1 (ru) * 1992-05-08 1998-02-20 Дзе Апджон Компани Производное оксазолидинона или его фармацевтически приемлемая соль, способ лечения микробных инфекций у теплокровных животных
WO1995007271A1 (en) * 1993-09-09 1995-03-16 The Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
WO1996013502A1 (en) * 1994-10-26 1996-05-09 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
WO1997027188A1 (en) * 1996-01-27 1997-07-31 Zeneca Limited Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163043B2 (en) 2003-12-18 2015-10-20 Dong-A St Co., Ltd. Oxazolidinone derivatives
US9624250B2 (en) 2009-02-03 2017-04-18 Merck Sharp & Dohme Corp. Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US9988406B2 (en) 2009-02-03 2018-06-05 Merck Sharp & Dohme Corp. Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US10065947B1 (en) 2009-02-03 2018-09-04 Merck Sharp & Dohme Corp. Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US10442829B2 (en) 2009-02-03 2019-10-15 Merck Sharp & Dohme Corp. Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate

Also Published As

Publication number Publication date
HRP20030522A2 (en) 2005-06-30
RU2003123104A (ru) 2005-03-10
NO20032926L (no) 2003-08-25
IL156662A0 (en) 2004-01-04
US20040059120A1 (en) 2004-03-25
JP2004525876A (ja) 2004-08-26
US20030065175A1 (en) 2003-04-03
EP1345913A2 (en) 2003-09-24
NZ526716A (en) 2005-08-26
BG108022A (bg) 2004-09-30
CZ20031799A3 (cs) 2004-02-18
US7183301B2 (en) 2007-02-27
MXPA03005822A (es) 2004-05-04
EE200300254A (et) 2003-12-15
CA2433138A1 (en) 2002-07-04
CN1656083A (zh) 2005-08-17
KR20030063472A (ko) 2003-07-28
NO20032926D0 (no) 2003-06-25
YU52403A (sh) 2006-03-03
PL363616A1 (en) 2004-11-29
WO2002051819A9 (en) 2003-08-07
HUP0302580A2 (hu) 2003-11-28
US7030148B2 (en) 2006-04-18
BR0116571A (pt) 2004-03-02
WO2002051819A2 (en) 2002-07-04
WO2002051819A3 (en) 2002-12-05
SK8202003A3 (en) 2004-07-07

Similar Documents

Publication Publication Date Title
RU2203897C2 (ru) Производные бензамидина, способ их получения, фармацевтическая композиция, способ ее получения и лекарственное средство
US6605609B2 (en) Thizaine oxazolidinone
RU2003123104A (ru) Новые гетероциклические соединения, имеющие антибактериальную активность:способ их получения и фармацевтические композиции, содеержащие их
RU2004111285A (ru) Оксазолидинон и/или изоксазолин в качестве антибактериальных средств
JP2022548247A5 (enExample)
RU2348628C2 (ru) Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
CA2427206A1 (en) Sulfamides as gamma-secretase inhibitors
RU2009133259A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
CA2568356A1 (en) Bicyclic heterocycles as hiv integrase inhibitors
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
JP2006506455A5 (enExample)
KR890008155A (ko) 신규인 유도체, 그 제조방법 및 의약에서의 사용
JP2004525876A5 (enExample)
RU2004139122A (ru) Производные n-бензоилуреидокоричной кислоты, способ их получения и их применение
CA2433039A1 (en) Agent for therapeutic and prophylactic treatment of neuropathic pain
MXPA04009356A (es) Administracion parenteral, intravenosa y oral de oxazolidinonas para tratar infecciones de pie diabetico.
JP2021510709A5 (enExample)
TW200403240A (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
RU94043786A (ru) Замещенные фенилкарбаматы и фенилмочевины, способ их получения и их применение в качестве 5-нт-антагонистов
DE59504161D1 (de) Carbamoylcarbonsäureamide
AU2001247540B2 (en) Novel benzosultam oxazolidinone antibacterial agents
PE20011088A1 (es) Tratamiento de infecciones del tracto urinario con oxazolidinonas antibacterianas
US20040072842A1 (en) Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
TH54154A (th) ออกซะโซลิดิโนน ไธโอแอมีด ซึ่งมีหมู่พิเพอราซีน แอมีดแทนที่
RU97120233A (ru) N-гидроксимочевины в качестве противовоспалительных средств

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20081227